Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides.
Xinbo YangLee I GarnerIvan V ZvyaginMichael A PaleyEkaterina A KomechKevin M JudeXiang ZhaoRicardo A FernandesLynn M HassmanGrace L PaleyChristina S SavvidesSimon BrackenridgeMax N QuastelDmitriy M ChudakovPaul BownessWayne M YokoyamaAndrew J McMichaelGeraldine M GillespieK Christopher GarciaPublished in: Nature (2022)
Human leucocyte antigen B*27 (HLA-B*27) is strongly associated with inflammatory diseases of the spine and pelvis (for example, ankylosing spondylitis (AS)) and the eye (that is, acute anterior uveitis (AAU)) 1 . How HLA-B*27 facilitates disease remains unknown, but one possible mechanism could involve presentation of pathogenic peptides to CD8 + T cells. Here we isolated orphan T cell receptors (TCRs) expressing a disease-associated public β-chain variable region-complementary-determining region 3β (BV9-CDR3β) motif 2-4 from blood and synovial fluid T cells from individuals with AS and from the eye in individuals with AAU. These TCRs showed consistent α-chain variable region (AV21) chain pairing and were clonally expanded in the joint and eye. We used HLA-B*27:05 yeast display peptide libraries to identify shared self-peptides and microbial peptides that activated the AS- and AAU-derived TCRs. Structural analysis revealed that TCR cross-reactivity for peptide-MHC was rooted in a shared binding motif present in both self-antigens and microbial antigens that engages the BV9-CDR3β TCRs. These findings support the hypothesis that microbial antigens and self-antigens could play a pathogenic role in HLA-B*27-associated disease.
Keyphrases
- ankylosing spondylitis
- dendritic cells
- microbial community
- amino acid
- rheumatoid arthritis
- endothelial cells
- healthcare
- lipopolysaccharide induced
- disease activity
- lps induced
- oxidative stress
- mental health
- liver failure
- regulatory t cells
- systemic lupus erythematosus
- inflammatory response
- case report
- respiratory failure
- extracorporeal membrane oxygenation
- dna binding
- adverse drug